NCT00049790已完成2 期
Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine the safety and efficacy of rhAngiostatin protein administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
rhEndostatin Protein Involving Pediatric Patients With CancerSolid TumorsNCT00165373Dana-Farber Cancer Institute21
已完成
4 期
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic PatientsType IIa and IIb HypercholesterolaemiaNCT00631189AstraZeneca668
Unknown
2 期
Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLCStaging IV NSCLCNCT04094909Guangzhou Institute of Respiratory Disease186
Unknown
4 期
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) StudyStage D Heart FailureNCT04191681The Cleveland Clinic50
已完成
3 期
The Effects of Atorvastatin in Patients With AtherosclerosisAtherosclerosisNCT00115817Brigham and Women's Hospital36